Gene expression analysis
Gene expression analysis is a genetic therapy with 225 clinical trials. Currently 4 active trials ongoing. Historical success rate of 85.6%.
Success Metrics
Based on 155 completed trials
Phase Distribution
Phase Distribution
38
Early Stage
43
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.0%
155 of 189 finished
18.0%
34 ended early
4
trials recruiting
225
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Clinical Trials (225)
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
The Role of Immune Checkpoints in Lung Transplant (ILTRA)
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Hepatobiliary Tumors Tissue Samples Acquisition
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 225